1. |
Oxman AD, Cook DJ, Guyatt GH. Users' guides to the medical literature. VI. How to use an overview. Evidence-Based Medicine Working Group. JAMA, 1994, 272:1367-1371.
|
2. |
Swingler GH, Volmink J, Ioannidis JP. Number of published systematic reviews and global burden of disease:database analysis. BMJ, 200, 327:1083-1084.
|
3. |
Murad MH, Montori VM. Synthesizing evidence:shifing the focus from individual studies to the body of evidence. JAMA, 2013, 309:2217-2218.
|
4. |
Cook DJ, Mulrow CD, Haynes RB. Systematic reviews:synthesis of best evidence for clinical decisions. Ann Intern Med, 1997, 126:376-380.
|
5. |
Shea BJ, Grimshaw JM, Wells GA, et al. Development of AMSTAR:a measurement tool to assess the methodological quality of systematic reviews. BMC Med Res Methodol, 2007, 7:10.
|
6. |
Wilson P, Petticrew M. Why promote the fndings of single research studies? BMJ, 2008, 336:722.
|
7. |
Petticrew M. Why certain systematic reviews reach uncertain conclusions. BMJ, 2003, 326:756-758.
|
8. |
Phan K, Tsai YC, Niranjan N, et al. Sutureless aortic valve replacement:a systematic review and meta-analysis. Ann Cardiothorac Surg, 2015, 4:100-111.
|
9. |
Armstrong R, Hall BJ, Doyle J, et al. Cochrane Update. 'Scoping the scope' of a cochrane review. J Public Health (Oxf), 2011, 33:147-150.
|
10. |
Wright CC, Sim J. Intention-to-treat approach to data from randomized controlled trials:a sensitivity analysis. J Clin Epidemiol, 2003, 56:833-842.
|
11. |
Oxman AD, Guyatt GH. A consumer's guide to subgroup analyses. Ann Intern Med, 1992, 116:78-84.
|
12. |
Horwitz RI. "Large-scale randomized evidence:large, simple trials and overviews of trials":discussion. A clinician's perspective on meta-analyses. J Clin Epidemiol, 1995, 48:41-44.
|
13. |
Eysenck HJ. Meta-analysis and its problems. BMJ, 1994, 309:789-792.
|
14. |
Cao C, Ang SC, Indraratna P, et al. Systematic review and meta-analysis of transcatheter aortic valve implantation versus surgical aortic valve replacement for severe aortic stenosis. Ann Cardiothorac Surg, 2013, 2:10-23.
|
15. |
Van der Wees P, Qaseem A, Kaila M, et al. Prospective systematic review registration:perspective from the Guidelines International Network (G-I-N). Syst Rev, 2012, 1:3.
|
16. |
Booth A, Clarke M, Dooley G, et al. PROSPERO at one year:an evaluation of its utility. Syst Rev, 2013, 2:4.
|
17. |
Smith BJ, Darzins PJ, Quinn M, et al. Modern methods of searching the medical literature. Med J Aust, 1992, 157:603-611.
|
18. |
Dickersin K, Scherer R, Lefebvre C. Identifying relevant studies for systematic reviews. BMJ, 1994, 309:1286-1291.
|
19. |
Dickersin K, Hewitt P, Mutch L, et al. Perusing the literature:comparison of MEDLINE searching with a perinatal trials database. Control Clin Trials, 1985, 6:306-317.
|
20. |
Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses:the PRISMA statement. J Clin Epidemiol, 2009, 62:1006-1012.
|
21. |
Dickersin K, Chan S, Chalmers TC, et al. Publication bias and clinical trials. Control Clin Trials, 1987, 8:343-353.
|
22. |
McAuley L, Pham B, Tugwell P, et al. Does the inclusion of grey literature influence estimates of intervention effectiveness reported in meta-analyses? Lancet, 2000, 356:1228-1231.
|
23. |
Cook DJ, Guyatt GH, Ryan G, et al. Should unpublished data be included in meta-analyses? Current convictions and controversies. JAMA, 1993, 269:2749-2753.
|
24. |
Moher D, Jadad AR, Nichol G, et al. Assessing the quality of randomized controlled trials:an annotated bibliography of scales and checklists. Control Clin Trials, 1995, 16:62-73.
|
25. |
Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials:is blinding necessary? Control Clin Trials, 1996, 17:1-12.
|
26. |
Higgins JP, Altman DG, Gøtzsche PC, et al. Te Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ, 2011, 343:d5928.
|
27. |
Sackett DL, Rosenberg WM, Gray JA, et al. Evidence based medicine:what it is and what it isn't. BMJ, 1996, 312:71-72.
|
28. |
Begg C, Cho M, Eastwood S, et al. Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA, 1996, 276:637-639.
|
29. |
von Elm E, Altman DG, Egger M, et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement:guidelines for reporting observational studies. BMJ, 2007, 335:806-808.
|
30. |
von Elm E, Egger M. Te scandal of poor epidemiological research. BMJ, 2004, 329:868-869.
|
31. |
Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology:a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA, 2000, 283:2008-2012.
|
32. |
Phan K, Ha H, Phan S, et al. Early hemodynamic performance of the third generation St Jude Trifecta aortic prosthesis:systematic review and meta-analysis. J Torac Cardiovasc Surg, 2015, [Epub ahead of print].
|
33. |
Lau J, Schmid CH, Chalmers TC. Cumulative meta-analysis of clinical trials builds evidence for exemplary medical care. J Clin Epidemiol, 1995, 48:45-60.
|
34. |
Lau J, Antman EM, Jimenez-Silva J, et al. Cumulative meta-analysis of therapeutic trials for myocardial infarction. N Engl J Med, 1992, 327:248-254.
|
35. |
Villanueva EV, Zavarsek S. Evaluating heterogeneity in cumulative meta-analyses. BMC Med Res Methodol, 2004, 4:18.
|
36. |
Phan K, Xie A, Di Eusanio M, et al. A meta-analysis of minimally invasive versus conventional sternotomy for aortic valve replacement. Ann Torac Surg, 2014, 98:1499-1511.
|
37. |
Phan K, Xie A, La Meir M, et al. Surgical ablation for treatment of atrial fbrillation in cardiac surgery:a cumulative meta-analysis of randomised controlled trials. Heart, 2014, 100:722-730.
|
38. |
Lewis S, Clarke M. Forest plots:trying to see the wood and the trees. BMJ, 2001, 322:1479-1480.
|
39. |
Phan K, Xie A, Tsai YC, et al. Ministernotomy or minithoracotomy for minimally invasive aortic valve replacement:a Bayesian network meta-analysis. Ann Cardiothorac Surg, 2015, 4:3-14.
|
40. |
Thompson SG. Why sources of heterogeneity in meta-analysis should be investigated. BMJ, 1994, 309:1351-1355.
|
41. |
Rücker G, Schwarzer G, Carpenter JR, et al. Undue reliance on I(2) in assessing heterogeneity may mislead. BMC Med Res Methodol, 2008, 8:79.
|
42. |
Jüni P, Altman DG, Egger M. Systematic reviews in health care:Assessing the quality of controlled clinical trials. BMJ, 2001, 323:42-46.
|
43. |
Baker WL, White CM, Cappelleri JC, et al. Understanding heterogeneity in meta-analysis:the role of meta-regression. Int J Clin Pract, 2009, 63:1426-1434.
|
44. |
Tompson SG, Higgins JP. How should meta-regression analyses be undertaken and interpreted? Stat Med, 2002, 21:1559-1573.
|
45. |
Phan K, Zhou JJ, Niranjan N, et al. Minimally invasive reoperative aortic valve replacement:a systematic review and meta-analysis. Ann Cardiothorac Surg, 2015, 4:15-25.
|
46. |
Caldwell DM, Ades AE, Higgins JP. Simultaneous comparison of multiple treatments:combining direct and indirect evidence. BMJ, 2005, 331:897-900.
|
47. |
Sutton A, Ades AE, Cooper N, et al. Use of indirect and mixed treatment comparisons for technology assessment. Pharmacoeconomics, 2008, 26:753-767.
|
48. |
Caldwell DM, Welton NJ, Ades AE. Mixed treatment comparison analysis provides internally coherent treatment effect estimates based on overviews of reviews and can reveal inconsistency. J Clin Epidemiol, 2010, 63:875-882.
|
49. |
Salanti G. Indirect and mixed-treatment comparison, network, or multiple-treatments meta-analysis:many names, many benefits, many concerns for the next generation evidence synthesis tool. Research Synthesis Methods, 2012, 3:80-97.
|
50. |
Jansen JP, Naci H. Is network meta-analysis as valid as standard pairwise meta-analysis? It all depends on the distribution of effect modifers. BMC Med, 2013, 11:159.
|
51. |
Caldwell DM, Gibb DM, Ades AE. Validity of indirect comparisons in meta-analysis. Lancet, 2007, 369:270-author reply 271.
|
52. |
Sturtz S, Bender R. Unsolved issues of mixed treatment comparison meta-analysis:network size and inconsistency. Research Synthesis Methods, 2012, 3:300-311.
|
53. |
Song F, Xiong T, Parekh-Bhurke S, et al. Inconsistency between direct and indirect comparisons of competing interventions:metaepidemiological study. BMJ, 2011, 343:d4909.
|
54. |
Dear KB. Iterative generalized least squares for meta-analysis of survival data at multiple times. Biometrics, 1994, 50:989-1002.
|
55. |
Arends LR, Hunink MG, Stijnen T. Meta-analysis of summary survival curve data. Stat Med, 2008, 27:4381-4396.
|
56. |
Fiocco M, Putter H, van Houwelingen JC. Meta-analysis of pairs of survival curves under heterogeneity:a Poisson correlated gammafrailty approach. Stat Med, 2009, 28:3782-3897.
|
57. |
Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med, 1998, 17:2815-2134.
|
58. |
Tierney JF, Stewart LA, Ghersi D, et al. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials, 2007, 8:16.
|
59. |
Guyot P, Ades AE, Ouwens MJ, et al. Enhanced secondary analysis of survival data:reconstructing the data from published KaplanMeier survival curves. BMC Med Res Methodol, 2012, 12:9.
|
60. |
Tian DH, De Silva RP, Wang T, et al. Open surgical repair for chronic type B aortic dissection:a systematic review. Ann Cardiothorac Surg, 2014, 3:340-350.
|
61. |
Phan K, Ha HS, Phan S, et al. New-onset atrial fbrillation following coronary bypass surgery predicts long-term mortality:a systematic review and meta-analysis. Eur J Cardiothorac Surg, 2015.[Epub ahead of print].
|
62. |
Chalmers I. Underreporting research is scientific misconduct. JAMA, 1990, 263:1405-1408.
|
63. |
Easterbrook PJ, Berlin JA, Gopalan R, et al. Publication bias in clinical research. Lancet, 1991, 337:867-872.
|
64. |
Sterne JA, Sutton AJ, Ioannidis JP, et al. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ, 2011, 343:d4002.
|
65. |
Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ, 1997, 315:629-634.
|
66. |
Duval S, Tweedie R. Trim and fill:A simple funnel-plot-based method of testing and adjusting for publication bias in metaanalysis. Biometrics, 2000, 56:455-463.
|
67. |
Xie A, Phan K, Yan TD. Durability of continuous-flow lef ventricular assist devices:a systematic review. Ann Cardiothorac Surg, 2014, 3:547-556.
|
68. |
Tsai YC, Phan K, Munkholm-Larsen S, et al. Surgical left atrial appendage occlusion during cardiac surgery for patients with atrial fbrillation:a meta-analysis. Eur J Cardiothorac Surg, 2014.[Epub ahead of print].
|
69. |
Man-Son-Hing M, Laupacis A, O'Rourke K, et al. Determination of the clinical importance of study results. J Gen Intern Med, 2002, 17:469-476.
|
70. |
Guyatt GH, Oxman AD, Vist GE, et al. GRADE:an emerging consensus on rating quality of evidence and strength of recommendations. BMJ, 2008, 336:924-926.
|
71. |
Balshem H, Helfand M, Schünemann HJ, et al. GRADE guidelines:3. Rating the quality of evidence. J Clin Epidemiol, 2011, 64:401-406.
|
72. |
Seco M, Cao C, Modi P, et al. Systematic review of robotic minimally invasive mitral valve surgery. Ann Cardiothorac Surg, 2013, 2:704-716.
|